These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9692687)

  • 1. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users.
    Cullen D; Bardhan KD; Eisner M; Kogut DG; Peacock RA; Thomson JM; Hawkey CJ
    Aliment Pharmacol Ther; 1998 Feb; 12(2):135-40. PubMed ID: 9692687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Hawkey CJ
    Am J Med; 1998 Mar; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
    N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study.
    Ekström P; Carling L; Wetterhus S; Wingren PE; Anker-Hansen O; Lundegårdh G; Thorhallsson E; Unge P
    Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of omeprazole on healing and appearance of small gastric and duodenal lesions during dosing with diclofenac in healthy subjects.
    Dorta G; Nicolet M; Vouillamoz D; Margalith D; Saraga E; Bouzourene H; Häcki WH; Stolte M; Blum AL; Armstrong D
    Aliment Pharmacol Ther; 2000 May; 14(5):535-41. PubMed ID: 10792115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study.
    Bianchi Porro G; Lazzaroni M; Imbesi V; Montrone F; Santagada T
    Dig Liver Dis; 2000 Apr; 32(3):201-8. PubMed ID: 10975769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
    Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
    Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
    N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
    Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR
    Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present position in the prevention and therapy of NSAID-induced ulcers].
    Lehmann FS; Beglinger C
    Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole 20 or 40 mg daily for healing gastroduodenal ulcers in patients receiving non-steroidal anti-inflammatory drugs.
    Massimo Claar G; Monaco S; Del Veccho Blanco C; Capurso L; Fusillo M; Annibale B
    Aliment Pharmacol Ther; 1998 May; 12(5):463-8. PubMed ID: 9663727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer.
    Bianchi Porro G; Lazzaroni M; Manzionna G; Petrillo M
    Aliment Pharmacol Ther; 1998 Apr; 12(4):355-60. PubMed ID: 9690725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee.
    Yeomans ND
    Am J Med; 1998 Mar; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal antiinflammatory drug-induced gastroduodenal lesions: prophylaxis and treatment.
    Zfass AM; McHenry L; Sanyal AJ
    Gastroenterologist; 1993 Jun; 1(2):165-9. PubMed ID: 8049889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20 mg in healthy subjects: a randomized, double-blind, placebo-controlled study.
    Desai JC; Sanyal SM; Goo T; Benson AA; Bodian CA; Miller KM; Cohen LB; Aisenberg J
    Dig Dis Sci; 2008 Aug; 53(8):2059-65. PubMed ID: 18224442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulglycotide in the prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal mucosal injury. A controlled double-blind, double-dummy, randomized endoscopic study versus placebo in rheumatic patients.
    Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Ardizzone S
    Scand J Gastroenterol; 1993 Oct; 28(10):875-8. PubMed ID: 8266016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.